Skip to content 
Cancer diagnostics have advanced rapidly in recent years, giving doctors and patients the tools to detect disease earlier and personalize treatment more effectively. One of the world leaders in this field is RGCC International, a Switzerland-based biotech company known for its cutting-edge molecular and blood-based tests.
For patients and healthcare providers in Pakistan, Leader Laboratories brings these same RGCC International tests locally, making it easier to access world-class diagnostics without the challenges of international testing. This partnership ensures that patients receive accurate, timely, and reliable results, helping doctors make informed decisions for better outcomes.
About RGCC International
Founded in 2004, RGCC International (Research Genetic Cancer Centre International GmbH) has built a global reputation for personalized oncology testing. Their main focus is on blood-based diagnostics, genetic profiling, and circulating tumor cell analysis, which allow doctors to understand the unique characteristics of each patient’s cancer.
The goal of RGCC tests is simple but powerful: detect cancer early, monitor disease progression, and provide personalized treatment options. These tests are not just lab procedures; they are tools that guide therapy decisions and improve the overall quality of care for patients worldwide.
Leader Laboratories: Bringing RGCC Tests to Pakistan
Accessing RGCC International tests from Pakistan used to involve complicated logistics, including shipping samples abroad and waiting for extended processing times. Leader Laboratories has made this process simple by providing these tests locally.
With Leader Laboratories, patients in Pakistan can now access:
- Advanced molecular and blood-based diagnostics
- Timely results for faster treatment decisions
- The same scientific protocols and accuracy as RGCC International
- Professional guidance for doctors and patients in interpreting results
By offering these services locally, Leader Laboratories bridges the gap between global innovation and local healthcare needs, ensuring that cutting-edge cancer diagnostics are available where they are most needed.
Key RGCC Tests Provided by Leader Laboratories
Leader Laboratories offers several key RGCC tests, each designed to address different aspects of cancer diagnosis and treatment planning.
Onco-D-Clare is a blood-based screening test that detects early signs of cancer using circulating tumor cells (CTCs) and other molecular biomarkers. Early detection is critical, as it allows doctors to intervene sooner, increasing the chances of successful treatment.
ChemoSNiP is a predictive test that evaluates how a patient metabolizes chemotherapy drugs. This allows doctors to choose the most effective therapy while minimizing side effects.
CAMBISeq uses next-generation sequencing to analyze tumor DNA for mutations. This detailed genetic information helps guide personalized therapy plans, including targeted treatments and emerging therapies.
Metastat monitors markers related to cancer spread, helping doctors track the progression of the disease and adjust treatment strategies accordingly.
Immune-Frame profiles the patient’s immune response to cancer, offering insights into potential immunotherapy options.
ArrayCGH (Array Comparative Genomic Hybridization) detects chromosomal abnormalities in tumor cells, providing precise genetic data that can guide treatment decisions.
All these tests are RGCC International tests provided locally by Leader Laboratories, ensuring that patients in Pakistan have access to advanced diagnostics with expert support.
Benefits of RGCC Tests Through Leader Laboratories
Accessing RGCC tests via Leader Laboratories offers many advantages for both patients and healthcare providers:
- Early Detection: Identifying cancer before symptoms appear improves treatment outcomes.
- Personalized Treatment: Therapy can be tailored to the patient’s unique genetic and molecular profile.
- Monitoring Progress: Doctors can track tumor progression and response to treatment over time.
- Local Access: No need to send samples abroad, reducing delays and costs.
- Expert Support: Leader Laboratories provides guidance in understanding and interpreting complex results.
By combining global expertise with local access, Leader Laboratories makes advanced cancer diagnostics practical and actionable for healthcare providers in Pakistan.
Improving Patient Care with Advanced Diagnostics
The primary aim of any cancer diagnostic test is to improve patient outcomes. RGCC International tests, provided locally by Leader Laboratories, help achieve this by giving doctors molecular-level insights into each patient’s cancer.
These tests enable:
- Early identification of cancer and pre-symptomatic detection
- Informed treatment decisions based on scientific evidence
- Selection of the most effective therapies, reducing trial-and-error approaches
- Confidence for patients knowing that advanced testing is available locally
Leader Laboratories ensures that these benefits are available to doctors and patients across Pakistan, supporting a more precise, patient-centered approach to oncology care.
How to Access RGCC Tests in Pakistan
Patients and healthcare providers in Pakistan can access RGCC International tests through Leader Laboratories in a simple and reliable process:
- Consult a Doctor: Tests are provided based on medical consultation.
- Sample Collection: Blood samples are collected locally at Leader Laboratories.
- Analysis: Tests are performed following RGCC International protocols.
- Results: Doctors receive detailed reports to guide therapy decisions.
For more information or to arrange testing, contact Leader Laboratories:
📞 Phone: +92 (42) 3576 3338
📧 Email: info@leaderlaboratories.co
Conclusion
RGCC International | Provided by Leader Laboratories ensures that advanced cancer diagnostics are accessible in Pakistan with the same accuracy and reliability as anywhere in the world.
By providing blood-based, molecular, and genetic tests locally, Leader Laboratories bridges the gap between international innovation and local healthcare needs. Patients and doctors now have access to personalized, evidence-based cancer care, enabling informed treatment decisions and improving outcomes.
For healthcare providers and patients seeking state-of-the-art oncology diagnostics, Leader Laboratories is the trusted provider of RGCC International tests in Pakistan.
